Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Canada
  4. CANADIAN NATIONAL STOCK EXCHANGE
  5. Medcolcanna Organics Inc.
  6. News
  7. Summary
    MCCN   CA58406X1050

MEDCOLCANNA ORGANICS INC.

(MCCN)
Delayed CANADIAN NATIONAL STOCK EXCHANGE  -  10:05 2022-07-06 am EDT
0.005000 CAD   -66.67%
08/10Medcolcanna Organics Inc. Announces Execution of Two Definitive Colombian Supply Agreements and Two Eu Sales Agreements for EUGMP and Cums-Imc Certified Dried Flower
CI
07/11IIROC Trading Halt - MCCN
AQ
05/10Medcolcanna Organics Inc. Announces Resignation of Pablo Abba Vieira as A Member of the Board of Director
CI
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Medcolcanna Organics Inc. Announces Execution of Two Definitive Colombian Supply Agreements and Two Eu Sales Agreements for EUGMP and Cums-Imc Certified Dried Flower

08/10/2022 | 12:19pm EST

Medcolcanna Organics Inc. announced the execution of two Definitive Colombian Supply Agreements and two EU Sales Agreements for EUGMP and CUMS-IMC certified Dried Flower. The executed agreements are for the purchase of 1,200 and up to 8,000 kilos per year of indoor grown and EUGMP certified dried flower as well as 800 kilos of CUMS-IMC certified Dried Flower. MCCN has also signed two definitive agreements for the sale of and distribution of the EUGMP and CUMS-IMC certified Dried Flower.

The terms outlined in the definitive Colombian supply agreements include the purchase and sale of THC Dried Flower. MCCN is to purchase 100% of the existing capacity (1,200 kilos per year) and 100% of the grower's expanded capacity up to 8,000 kilos per year, this supply is produced from the only indoor facility in Colombia. The agreement is for a three-year term with the possibility to extend the term.

The grower has obtained the EUGMP certification, which commands a market premium for sales into the European Union. Medcolcanna expects to receive the first shipment in October 2022. The grower expects to complete its first expansion by late Q4-2022 which will increase its production by approximately 4,000 kilos of annualized production The agreement establishes a long-term supply partnership, with the contract having a three-year term, with the possibility of extending the term.

Working capital has been provided by MCCN to the supplier as a condition to the agreement. The quota for the export of THC has been granted to MCCN MCCN has applied to the Colombian Government to allocate a portion of its THC quota to this supplier and is expecting the approval to occur shortly. The approval of the allocation of the quota to the supplier to perform its obligation to grow at their indoor GMP EU certified facility.

MCCN is providing its genetics to the supplier, to utilize in their indoor facility. The second Colombian Supply Agreement is for MCCN to purchase 800 kilos of CUMS-IMC certified dried flower per year. The grower has a state of the art, climate control polycarbonate Greenhouse infrastructure with supplemental lights to guarantee indoor quality production.

The grower has obtained the Israel CUMS-IMC certification, which commands a market premium for sales into Israel. Medcolcanna expects to receive the first shipment in late October or November 2022. The agreement establishes a long-term supply partnership, with the contract having a two-year term, with the possibility of extending the term.

THC quotas has been granted and allocated to the supplier approved by the government and ready to start cultivation.


ę S&P Capital IQ 2022
All news about MEDCOLCANNA ORGANICS INC.
08/10Medcolcanna Organics Inc. Announces Execution of Two Definitive Colombian Supply Agreem..
CI
07/11IIROC Trading Halt - MCCN
AQ
05/10Medcolcanna Organics Inc. Announces Resignation of Pablo Abba Vieira as A Member of the..
CI
03/17Medcolcanna Organics Inc. announced that it has received CAD 2.5 million in funding
CI
02/14Medcolcanna Organics Inc. announced that it expects to receive CAD 2.5 million in fundi..
CI
2019Medcolcanna Organics Inc Announces Management Changes
CI
More news
Financials
Sales 2020 0,10 M 0,07 M 0,07 M
Net income 2020 -7,27 M -5,40 M -5,40 M
Net Debt 2020 2,98 M 2,21 M 2,21 M
P/E ratio 2020 -1,00x
Yield 2020 -
Capitalization 0,85 M 0,63 M 0,63 M
EV / Sales 2019 4 531x
EV / Sales 2020 116x
Nbr of Employees 90
Free-Float 28,6%
Chart MEDCOLCANNA ORGANICS INC.
Duration : Period :
Medcolcanna Organics Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Felipe de la Vega Vargara President, Chief Executive Officer & Director
Christopher Donald Reid Chief Financial Officer
Robert James Metcalfe Chairman
Ana MarÝa Borda Director-Research & Development
Nicolas Rodriguez Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
MEDCOLCANNA ORGANICS INC.-90.00%1
JOHNSON & JOHNSON4.57%467 679
ELI LILLY AND COMPANY34.07%356 089
ABBVIE INC.20.87%289 331
NOVO NORDISK A/S22.04%285 887
PFIZER, INC.-13.50%285 774